{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:27:23Z","timestamp":1772000843531,"version":"3.50.1"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:p>\n                    Owing to the drawbacks and adverse effects associated with conventional cancer therapies, there is growing interest in identifying effective natural alternatives. In this study, the anticancer potential of honeybee and scorpion venoms was evaluated using three human cancer cell lines: lung adenocarcinoma (A549), colon carcinoma (HCT-116), and breast adenocarcinoma (MDA-MB-231). The chemical composition, biological activity, and molecular interactions of both venoms with key cancer-related targets were investigated through gas chromatography\u2013mass spectrometry (GC-MS), cytotoxicity assays, gene expression analysis, and molecular docking. GC-MS analysis revealed that scorpion venom was predominantly composed of methyl isocyanide, 3-butyn-1-ol, and allene, whereas honeybee venom was characterized by caprylic anhydride, 1,3,5-triazine derivatives, and palmitin as major bioactive constituents. Functional analyses demonstrated that both venoms modulated the expression of genes associated with apoptosis and other cancer-related pathways rather than inducing apoptosis directly. Notably, scorpion venom significantly downregulated the anti-apoptotic gene\n                    <jats:italic>Bcl-2<\/jats:italic>\n                    , whereas honeybee venom upregulated its expression, indicating distinct mechanisms of action. Scorpion venom exerted pronounced pro-apoptotic effects, while honeybee venom appeared to act primarily through immunomodulatory and anti-angiogenic pathways. Molecular docking analyses confirmed favorable interactions between venom-derived compounds and key molecular targets, including Bcl-2, Bax, p53, and VEGF, supporting their potential as multi-target anticancer agents. Collectively, these findings demonstrate that honeybee and scorpion venoms possess promising anticancer properties via distinct yet complementary mechanisms, with particular efficacy against lung and breast adenocarcinoma cell lines. The results highlight the potential of these venoms as natural candidates for the development of alternative anticancer therapeutics.\n                  <\/jats:p>","DOI":"10.3389\/ftox.2026.1756933","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:33:39Z","timestamp":1771997619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparison of honeybee and scorpion venoms as anticancer agents against three different cancer cell lines: lung, colon, and breast cancer"],"prefix":"10.3389","volume":"8","author":[{"given":"Fatma H.","family":"Galal","sequence":"first","affiliation":[{"name":"Department of Biology, College of Science, Jouf University","place":["Sakaka, Aljouf, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad M.","family":"Alshammari","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Jouf University","place":["Sakaka, Aljouf, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman S.","family":"Aldaghmi","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Jouf University","place":["Sakaka, Aljouf, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed E.","family":"Hafez","sequence":"additional","affiliation":[{"name":"Plant Protection and Biomolecular Diagnosis Department, ALCRI, City of Scientific Research and Technological Applications","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada M.","family":"El-Sayed","sequence":"additional","affiliation":[{"name":"Microbial Genetic Department, Biotechnology Research Institute, National Research Centre","place":["Cairo, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyadh H.","family":"Aeban","sequence":"additional","affiliation":[{"name":"Department of Medical Molecular Laboratory, Security Forces Hospital Makkah","place":["Makkah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad A.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Medical Molecular Laboratory, Security Forces Hospital Makkah","place":["Makkah, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"189479","DOI":"10.1016\/j.bbcan.2025.189479","article-title":"Snake venom-derived peptides as anticancer candidates: pioneering next-generation therapies","volume":"1880","author":"Almeida","year":"2025","journal-title":"Biochimica Biophysica Acta Rev. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"103134","DOI":"10.1016\/j.jksus.2024.103134","article-title":"Network pharmacology and molecular docking analysis of Catharanthus roseus compounds: implications for non-small cell lung cancer treatment","volume":"36","author":"Alsaif","year":"2024","journal-title":"J. King Saud University\u2013Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00520-021-06513-1","article-title":"Colorectal cancer survival: prevalence of psychosocial distress and unmet supportive care needs","volume":"30","author":"Andreu","year":"2022","journal-title":"Support. Care Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00018.2016","article-title":"Ion channels and transporters in cancer","volume":"97","author":"Arcangeli","year":"2017","journal-title":"Physiol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"768556","DOI":"10.3389\/fphar.2022.768556","article-title":"Molecular docking as a therapeutic approach for cancer stem cell metabolism","volume":"13","author":"Arjmand","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B82","first-page":"43","article-title":"Snake Venoms-Based Compounds as Potential Anticancer Prodrug: Sand Viper Cerastes Cerastes as a Model","volume":"65","author":"Aziz","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"B6","article-title":"Anticancer activity of bee venom against lung cancer cell line (A549 cells) enhanced by iron oxide nanoparticles synthesized from Syzygium aromaticum","volume":"9","author":"Bagyalakshmi","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","article-title":"Current cancer burden in China","volume":"19","author":"Cao","year":"2022","journal-title":"Cancer Biol. and Med."},{"key":"B8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/B978-0-323-62539-5.00029-1","article-title":"Cancer rehabilitation","volume-title":"Braddom\u2019s physical medicine and rehabilitation","author":"Cheville","year":"2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1022123","DOI":"10.3389\/fonc.2022.1022123","article-title":"Neoadjuvant immunotherapy combined with chemotherapy significantly improved overall survival compared with neoadjuvant chemotherapy in non-small cell lung cancer: a cohort study","volume":"12","author":"Dai","year":"2022","journal-title":"Front. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1590\/s1984-82502011000400017","article-title":"Pharmacokinetic study with computational tools in the medicinal chemistry course","volume":"47","author":"de Brito","year":"2011","journal-title":"Braz. J. Pharm. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/toxins15050327","article-title":"Use of botulinum toxin as a treatment of hemiplegic shoulder pain syndrome: a randomized trial","volume":"15","author":"de Melo Carvalho Rocha","year":"2023","journal-title":"Toxins"},{"key":"B13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/toxins14040248","article-title":"The enzymatic core of scorpion venoms","volume":"14","author":"Delgado-Prudencio","year":"2022","journal-title":"Toxins"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1674791","DOI":"10.3389\/fbinf.2025.1674791","article-title":"Unraveling the molecular basis of snake venom nerve growth factor: human TrkA recognition through molecular dynamics simulation and comparison with human nerve growth factor","volume":"5","author":"Devi","year":"2025","journal-title":"Front. Bioinforma."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.3390\/molecules28227609","article-title":"Norcantharidin-encapsulated C60-modified nanomicelles: a potential approach to mitigate cytotoxicity in renal cells and enhance anti-tumor activity in hepatocellular carcinoma cells","volume":"28","author":"Ding","year":"2023","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"B17","doi-asserted-by":"publisher","first-page":"132176","DOI":"10.1016\/j.ijbiomac.2024.132176","article-title":"Biological activities of fig latex-loaded cellulose acetate\/poly(ethylene oxide) nanofiber for potential therapeutics: anticancer and antioxidant material","volume":"270","author":"El-Fawal","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40643-024-00805-0","article-title":"Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy","volume":"11","author":"El-Qassas","year":"2024","journal-title":"Bioresour. Bioprocess."},{"key":"B19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21608\/jesp.2019.68305","article-title":"Effect of bee and scorpion venoms on prostate cancer: an in vitro study","volume":"49","author":"Elfiky","year":"2019","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.3390\/molecules30194003","article-title":"Therapeutic bioactivity exerted by Apis mellifera bee venom and its major protein melittin: a scoping review","volume":"30","author":"Erdo\u011fan","year":"2025","journal-title":"Molecules"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e12310917802","DOI":"10.33448\/rsd-v10i9.17802","article-title":"Assist\u00eancia do enfermeiro diante do c\u00e2ncer de mama","volume":"10","author":"Ferreira","year":"2021","journal-title":"Res. Soc. Dev."},{"key":"B22","first-page":"E01","article-title":"Arthropod venom peptides: pioneering nanotechnology in cancer treatment and drug delivery","volume":"3","author":"Ghodeif","year":"2025","journal-title":"Cancer Pathogenesis Ther."},{"key":"B85","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1038\/s41467-023-44084-3","article-title":"Chemical modulation of cytosolic BAX homodimer potentiates BAX activation and apoptosis","volume":"14","author":"Gitego","year":"2023","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","article-title":"Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells","volume":"184","author":"Glassman","year":"2021","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jobcr.2025.08.024","article-title":"SND1 as a novel m6A regulator in head and neck cancer","volume":"15","author":"Gopalakrishnan","year":"2025","journal-title":"J. Oral Biol. Craniofacial Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","article-title":"Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity","volume":"40","author":"Hailemichael","year":"2022","journal-title":"Cancer Cell"},{"key":"B25","first-page":"85","article-title":"The effects of melittin coding gene of bee venom on bcl-2 and bax gene expression in ACHN cells","volume":"18","author":"Heidari Esfahani","year":"2021","journal-title":"Anatomical Sci. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.tibs.2018.07.001","article-title":"Venoms to the rescue: therapeutic applications of animal venoms","volume":"43","author":"Holford","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxres\/tfaa012","article-title":"Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and\/or muramyl dipeptide in tumor-bearing mice","volume":"9","author":"Ibrahim","year":"2020","journal-title":"Toxicol. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.tiv.2014.02.004","article-title":"Cytotoxicity and gene expression profiling of polyhexamethylene guanidine hydrochloride in human alveolar A549 cells","volume":"28","author":"Jung","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"B83","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1007\/s00044-013-0564-x","article-title":"In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules","volume":"22","author":"Kalsoom","year":"2013","journal-title":"Med. Chem. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/toxins17100477","article-title":"Anticancer activity of snake venom against breast cancer: a scoping review","volume":"17","author":"Kim","year":"2025","journal-title":"Toxins"},{"key":"B87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/protein\/gzw003","article-title":"Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics","volume":"29","author":"Klarenbeek","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"B80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-817907-9.00007-6","article-title":"Natural bee products and their apitherapeutic applications","volume":"66","author":"Kolayli","year":"2020","journal-title":"Studies in Natural Products Chemistry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/antiox10020158","article-title":"Betulinic acid alleviates spleen oxidative damage induced by T-2 toxin","volume":"10","author":"Kong","year":"2021","journal-title":"Antioxidants"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/molecules27072219","article-title":"Anti-cancer activity of Buthus occitanus venom on hepatocellular carcinoma in 3D cell culture","volume":"27","author":"Lafnoune","year":"2022","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jncc.2024.04.004","article-title":"Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in first-line chemotherapy for ovarian cancer","volume":"4","author":"Li","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019","volume":"14","author":"Lin","year":"2021","journal-title":"J. Hematol. and Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/bph.16232","article-title":"Natural products targeting tumour angiogenesis","volume":"182","author":"Lu","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108542","DOI":"10.1016\/j.toxicon.2025.108542","article-title":"Scorpion venoms from the buthidae family: a dual study of proteomic composition and anticancer potentials","volume":"266","author":"Mabunda","year":"2025","journal-title":"Toxicon"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.3390\/cancers15143714","article-title":"Can bee venom be used as an anticancer agent in modern medicine?","volume":"15","author":"Ma\u0142ek","year":"2023","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105329","DOI":"10.1016\/j.bioorg.2021.105329","article-title":"Bee venom and its active component melittin synergistically potentiate the anticancer effect of sorafenib against HepG2 cells","volume":"116","author":"Mansour","year":"2021","journal-title":"Bioorg. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/cancers14061585","article-title":"The role of ROS as a double-edged sword in (in)fertility: the impact of cancer treatment","volume":"14","author":"Mendes","year":"2022","journal-title":"Cancers"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.5530\/pj.2024.16.123","article-title":"Comparative molecular simulation analysis of IL-6R\u03b1 with TCZ and HIL-6: mechanisms in inflammatory responses","volume":"16","author":"Merizka","year":"2024","journal-title":"Pharmacogn. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.3390\/nu15163604","article-title":"Association between pre-treatment biological indicators and compliance to neoadjuvant\/perioperative chemotherapy in operable gastric cancer","volume":"15","author":"Monti","year":"2023","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.intimp.2006.07.027","article-title":"Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells","volume":"6","author":"Moon","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.rpth.2025.102691","article-title":"Structural bioinformatics for rational drug design","volume":"9","author":"Mozaffari","year":"2025","journal-title":"Res. Pract. Thrombosis Haemostasis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"key":"B46","doi-asserted-by":"publisher","first-page":"24607","DOI":"10.1038\/s41598-024-75183-w","article-title":"Anticancer potentiality of Hottentotta saulcyi scorpion curd venom against breast cancer","volume":"14","author":"Nosouhian","year":"2024","journal-title":"Sci. Rep."},{"key":"B81","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jsps.2022.06.012","article-title":"Anti-cancer potency by induced apoptosis by molecular docking P53, caspase, cyclin D1, cytotoxicity analysis and phagocytosis activity of trisindoline 1, 3 and 4","volume":"30","author":"Nurhayati","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11033-024-09970-z","article-title":"Snake venom toxins as potential therapeutic agents in the treatment of prostate cancer","volume":"51","author":"Ochoa-Mosquera","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1177932219865533","DOI":"10.1177\/1177932219865533","article-title":"Homology modelling and molecular docking studies of substituted benzimidazole scaffolds","volume":"13","author":"Oduselu","year":"2019","journal-title":"Bioinforma. Biol. Insights"},{"key":"B49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-012-9345-0","article-title":"Bee venom in cancer therapy","volume":"31","author":"Or\u0161oli\u0107","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"B50","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.3390\/molecules25245959","article-title":"Toxicological screening of four bioactive citroflavonoids","volume":"25","author":"Ortiz-Andrade","year":"2020","journal-title":"Molecules"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminformatics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.4014\/jmb.2410.10016","article-title":"Shiga toxins induce inflammation through the p38 MAPK\/MK2\/TTP pathway","volume":"34","author":"Park","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/jal2020009","article-title":"Sarcopenia risk and food intake in older cancer patients","volume":"2","author":"Pimentel","year":"2022","journal-title":"J. Ageing Longev."},{"key":"B54","article-title":"In-silico investigation of drug likeness, toxicity, and molecular docking on lung cancer proteins","volume-title":"In silico research in biomedicine","author":"Pooja","year":"2025"},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","article-title":"Melittin and its conjugates in cancer therapy","volume":"402","author":"Rady","year":"2017","journal-title":"Cancer Lett."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7324\/japs.2025.220739","article-title":"Exploring snake venom-derived molecules for cancer treatment: challenges and opportunities","author":"Ramesh","year":"2025","journal-title":"J. Appl. Pharm. Sci"},{"key":"B88","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1021\/acsomega.2c07153","article-title":"Synthesis, molecular docking, and biological evaluation of a new series of benzothiazinones and their benzothiazinyl acetate derivatives as anticancer agents against MCF-7 human breast cancer cells and as anti-inflammatory agents","volume":"8","author":"Ramzan","year":"2023","journal-title":"ACS omega."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.5808\/gi.21062","article-title":"Molecular docking of bioactive compounds from Moringa oleifera with p53 protein","volume":"19","author":"Rath","year":"2021","journal-title":"Genomics and Inf."},{"key":"B58","doi-asserted-by":"publisher","first-page":"4759821","DOI":"10.1155\/2021\/4759821","article-title":"Synthesis, anticancer assessment, and molecular docking of chalcone\u2013thienopyrimidine derivatives","volume":"2021","author":"Safwat","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0239811","DOI":"10.1371\/journal.pone.0239811","article-title":"Cancer survivorship needs in Brazil","volume":"15","author":"Santos","year":"2020","journal-title":"PLOS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e202500365","DOI":"10.1002\/cmdc.202500365","article-title":"Molecular docking and target-specific binding profiles of benzosuberane-based compounds","volume":"20","author":"Saragatsis","year":"2025","journal-title":"ChemMedChem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.46439\/toxicology.5.021","article-title":"Identification of novel bioactivities from bee venom targeting TNF-\u03b1","volume":"5","author":"Saravanan","year":"2023","journal-title":"Archives Clin. Toxicol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3109\/14756366.2011.608663","article-title":"Molecular docking studies of anti-apoptotic proteins with ginsenosides","volume":"27","author":"Sathishkumar","year":"2012","journal-title":"J. Enzyme Inhibition Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"20495","DOI":"10.1039\/d5ra01257k","article-title":"Synthesis, cytotoxic activity, molecular docking, molecular dynamics simulations and ADMET studies of novel spiropyrazoline oxindoles","volume":"15","author":"Seliem","year":"2025","journal-title":"RSC Adv."},{"key":"B64","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pharmthera.2007.04.004","article-title":"Therapeutic application of bee venom and its components","volume":"115","author":"Son","year":"2007","journal-title":"Pharmacol. and Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"118636","DOI":"10.1016\/j.biopha.2025.118636","article-title":"Bee venom in pharmacology: mechanistic insights","volume":"192","author":"Sriwidodo","year":"2025","journal-title":"Biomed. and Pharmacother."},{"key":"B66","first-page":"13","article-title":"Molecular docking studies of important vitamins as inhibitors against cytokine targets","author":"Suwitono","year":"2022","journal-title":"8th Int. Sci. Strategic Challenges Conf. Proc."},{"key":"B67","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40360-025-00958-4","article-title":"In silico drug evaluation by molecular docking, ADME studies and DFT calculations","volume":"26","author":"Tahiro\u011flu","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/biom14050544","article-title":"Virtual screening of small molecules targeting BCL2 with machine learning, molecular docking, and MD simulation","volume":"14","author":"Tondar","year":"2024","journal-title":"Biomolecules"},{"key":"B68","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/09553002.2021.1913527","article-title":"Residential radon and lung cancer characteristics","volume":"97","author":"Torres-Duran","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"102791","DOI":"10.1016\/j.redox.2023.102791","article-title":"Action mechanism of snake venom L-amino acid oxidase in cancer treatment","volume":"64","author":"Truong","year":"2023","journal-title":"Redox Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jsps.2022.11.008","article-title":"Pharmacological properties and therapeutic potential of honey bee venom","volume":"31","author":"Ullah","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/toxins13060415","article-title":"Animal venoms and their components: molecular mechanisms of action","volume":"13","author":"Utkin","year":"2021","journal-title":"Toxins"},{"key":"B72","first-page":"169","article-title":"Evaluaci\u00f3n preliminar de la actividad antiviral del extracto acuoso de Phyllanthus orbicularis","volume":"55","author":"Vald\u00e9s-Garc\u00eda","year":"2003","journal-title":"Rev. Cubana Med. Trop."},{"key":"B73","doi-asserted-by":"publisher","first-page":"104137","DOI":"10.1016\/j.ibmb.2024.104137","article-title":"Androcin 18-1, a novel scorpion-venom peptide with antitumor activity","volume":"170","author":"Wang","year":"2024","journal-title":"Insect Biochem. Mol. Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms262010037","article-title":"Progress of AI-driven drug\u2013target interaction prediction and lead optimization","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/bioinformatics\/btt447","article-title":"Protein\u2013ligand binding site recognition","volume":"29","author":"Yang","year":"2013","journal-title":"Bioinformatics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.aspen.2019.09.001","article-title":"Assessment of hemolytic activity of bee venom against physicochemical factors","volume":"22","author":"Yousefpoor","year":"2019","journal-title":"J. Asia-Pacific Entomology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21859\/mci-supp-07","article-title":"Cytotoxicity of benzyl isoquinolinic alkaloids on breast cancer cell lines","volume":"1","author":"Zarei","year":"2017","journal-title":"Multidiscip. Cancer Investig."},{"key":"B78","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1111\/cas.14549","article-title":"Cucurmosin-based immunotoxin targeting PD-L1","volume":"111","author":"Zhang","year":"2020","journal-title":"Cancer Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cei\/uxad037","article-title":"Diagnostic markers and potential therapeutic agents for Sj\u00f6gren\u2019s syndrome","volume":"212","author":"Zhou","year":"2023","journal-title":"Clin. and Exp. Immunol."}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1756933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:33:42Z","timestamp":1771997622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1756933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":88,"alternative-id":["10.3389\/ftox.2026.1756933"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2026.1756933","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1756933"}}